IBDEI1LC ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28237,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28237,1,4,0)
 ;;=4^692.72
 ;;^UTILITY(U,$J,358.3,28237,1,5,0)
 ;;=5^Photosensitivity
 ;;^UTILITY(U,$J,358.3,28237,2)
 ;;=^93951
 ;;^UTILITY(U,$J,358.3,28238,0)
 ;;=692.6^^162^1793^45
 ;;^UTILITY(U,$J,358.3,28238,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28238,1,4,0)
 ;;=4^692.6
 ;;^UTILITY(U,$J,358.3,28238,1,5,0)
 ;;=5^Poison Ivy
 ;;^UTILITY(U,$J,358.3,28238,2)
 ;;=^271908
 ;;^UTILITY(U,$J,358.3,28239,0)
 ;;=698.0^^162^1793^47
 ;;^UTILITY(U,$J,358.3,28239,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28239,1,4,0)
 ;;=4^698.0
 ;;^UTILITY(U,$J,358.3,28239,1,5,0)
 ;;=5^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,28239,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,28240,0)
 ;;=698.9^^162^1793^46
 ;;^UTILITY(U,$J,358.3,28240,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28240,1,4,0)
 ;;=4^698.9
 ;;^UTILITY(U,$J,358.3,28240,1,5,0)
 ;;=5^Pruritic Disorder,Unsp
 ;;^UTILITY(U,$J,358.3,28240,2)
 ;;=^123977
 ;;^UTILITY(U,$J,358.3,28241,0)
 ;;=696.1^^162^1793^48
 ;;^UTILITY(U,$J,358.3,28241,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28241,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,28241,1,5,0)
 ;;=5^Psoriasis
 ;;^UTILITY(U,$J,358.3,28241,2)
 ;;=^87816
 ;;^UTILITY(U,$J,358.3,28242,0)
 ;;=287.0^^162^1793^49
 ;;^UTILITY(U,$J,358.3,28242,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28242,1,4,0)
 ;;=4^287.0
 ;;^UTILITY(U,$J,358.3,28242,1,5,0)
 ;;=5^Purpura, Vascular
 ;;^UTILITY(U,$J,358.3,28242,2)
 ;;=^101365
 ;;^UTILITY(U,$J,358.3,28243,0)
 ;;=782.1^^162^1793^50
 ;;^UTILITY(U,$J,358.3,28243,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28243,1,4,0)
 ;;=4^782.1
 ;;^UTILITY(U,$J,358.3,28243,1,5,0)
 ;;=5^Rash, NOS
 ;;^UTILITY(U,$J,358.3,28243,2)
 ;;=^102948
 ;;^UTILITY(U,$J,358.3,28244,0)
 ;;=706.2^^162^1793^54
 ;;^UTILITY(U,$J,358.3,28244,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28244,1,4,0)
 ;;=4^706.2
 ;;^UTILITY(U,$J,358.3,28244,1,5,0)
 ;;=5^Sebaceous Cyst
 ;;^UTILITY(U,$J,358.3,28244,2)
 ;;=^41304
 ;;^UTILITY(U,$J,358.3,28245,0)
 ;;=690.10^^162^1793^57
 ;;^UTILITY(U,$J,358.3,28245,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28245,1,4,0)
 ;;=4^690.10
 ;;^UTILITY(U,$J,358.3,28245,1,5,0)
 ;;=5^Seborrheic Dermatitis
 ;;^UTILITY(U,$J,358.3,28245,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,28246,0)
 ;;=702.11^^162^1793^55
 ;;^UTILITY(U,$J,358.3,28246,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28246,1,4,0)
 ;;=4^702.11
 ;;^UTILITY(U,$J,358.3,28246,1,5,0)
 ;;=5^Seborrh Keratosis, Inflammatory
 ;;^UTILITY(U,$J,358.3,28246,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,28247,0)
 ;;=702.19^^162^1793^56
 ;;^UTILITY(U,$J,358.3,28247,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28247,1,4,0)
 ;;=4^702.19
 ;;^UTILITY(U,$J,358.3,28247,1,5,0)
 ;;=5^Seborrh Keratosis, Other
 ;;^UTILITY(U,$J,358.3,28247,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,28248,0)
 ;;=686.9^^162^1793^58
 ;;^UTILITY(U,$J,358.3,28248,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28248,1,4,0)
 ;;=4^686.9
 ;;^UTILITY(U,$J,358.3,28248,1,5,0)
 ;;=5^Skin Infec, Local Unsp
 ;;^UTILITY(U,$J,358.3,28248,2)
 ;;=^123943
 ;;^UTILITY(U,$J,358.3,28249,0)
 ;;=708.9^^162^1793^71
 ;;^UTILITY(U,$J,358.3,28249,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28249,1,4,0)
 ;;=4^708.9
 ;;^UTILITY(U,$J,358.3,28249,1,5,0)
 ;;=5^Urticaria, Unsp
 ;;^UTILITY(U,$J,358.3,28249,2)
 ;;=^124650
 ;;^UTILITY(U,$J,358.3,28250,0)
 ;;=078.10^^162^1793^72
 ;;^UTILITY(U,$J,358.3,28250,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28250,1,4,0)
 ;;=4^078.10
 ;;^UTILITY(U,$J,358.3,28250,1,5,0)
 ;;=5^Warts
 ;;^UTILITY(U,$J,358.3,28250,2)
 ;;=^295787
 ;;^UTILITY(U,$J,358.3,28251,0)
 ;;=706.8^^162^1793^73
 ;;
 ;;$END ROU IBDEI1LC
